K. Balachandran

660 total citations
31 papers, 421 citations indexed

About

K. Balachandran is a scholar working on Organic Chemistry, Oncology and Renewable Energy, Sustainability and the Environment. According to data from OpenAlex, K. Balachandran has authored 31 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 10 papers in Oncology and 6 papers in Renewable Energy, Sustainability and the Environment. Recurrent topics in K. Balachandran's work include TiO2 Photocatalysis and Solar Cells (6 papers), Oxidative Organic Chemistry Reactions (5 papers) and Advanced Photocatalysis Techniques (5 papers). K. Balachandran is often cited by papers focused on TiO2 Photocatalysis and Solar Cells (6 papers), Oxidative Organic Chemistry Reactions (5 papers) and Advanced Photocatalysis Techniques (5 papers). K. Balachandran collaborates with scholars based in India, United Kingdom and Malta. K. Balachandran's co-authors include M. V. George, R. Venckatesh, Rajeshwari Sivaraj, M. V. George, Rajiv Periakaruppan, Alicia Okines, Sanjay Popat, Daniel L. Morganstein, R. Gunapala and S. Karthikeyan and has published in prestigious journals such as Chemical Reviews, Oncogene and The Lancet Oncology.

In The Last Decade

K. Balachandran

27 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Balachandran India 11 127 114 87 47 39 31 421
Qiaofeng Wang China 14 275 2.2× 187 1.6× 150 1.7× 32 0.7× 29 0.7× 46 736
Alfonso Enrique Ramírez Sanabria Colombia 12 90 0.7× 113 1.0× 265 3.0× 33 0.7× 8 0.2× 53 561
Jong Min Park South Korea 10 65 0.5× 80 0.7× 206 2.4× 68 1.4× 5 0.1× 16 428
Ahmed H. Osman Egypt 14 169 1.3× 23 0.2× 113 1.3× 29 0.6× 176 4.5× 54 624
Y. G. Xie China 11 53 0.4× 28 0.2× 91 1.0× 15 0.3× 9 0.2× 47 364
Ali Akbar Shekarchi Iran 9 110 0.9× 132 1.2× 250 2.9× 19 0.4× 32 0.8× 23 655
Robert M. Berger United States 14 109 0.9× 49 0.4× 121 1.4× 9 0.2× 215 5.5× 18 616
Jiaqi Tian China 13 211 1.7× 43 0.4× 68 0.8× 20 0.4× 7 0.2× 27 547
Ákos Szabó Hungary 12 112 0.9× 24 0.2× 60 0.7× 20 0.4× 10 0.3× 20 402
Lingling Shi China 11 186 1.5× 233 2.0× 252 2.9× 10 0.2× 10 0.3× 34 560

Countries citing papers authored by K. Balachandran

Since Specialization
Citations

This map shows the geographic impact of K. Balachandran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Balachandran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Balachandran more than expected).

Fields of papers citing papers by K. Balachandran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Balachandran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Balachandran. The network helps show where K. Balachandran may publish in the future.

Co-authorship network of co-authors of K. Balachandran

This figure shows the co-authorship network connecting the top 25 collaborators of K. Balachandran. A scholar is included among the top collaborators of K. Balachandran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Balachandran. K. Balachandran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Escriu, Carles, Riyaz Shah, Samantha Cox, et al.. (2024). Efficacy of carboplatin–etoposide rechallenge after first-line chemo-immunotherapy in ES-SCLC: an international multicentric analysis. Therapeutic Advances in Medical Oncology. 16. 12717693–12717693. 1 indexed citations
2.
Harrod, Alison, Chun‐Fui Lai, Daniela Barsotti Santos, et al.. (2022). Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer. Oncogene. 41(44). 4905–4915. 17 indexed citations
3.
Balachandran, K., Ashley Brown, Sarah Mahmoud, et al.. (2021). 176P Breast cancer treatment during the first wave of the COVID-19 pandemic at a UK centre. Annals of Oncology. 32. S94–S94. 1 indexed citations
4.
Kumar, P. Anil, et al.. (2021). Synthesis of Ag Decorated TiO2 Nanoparticles for Ammonia Gas Sensor Application. Journal of Environmental Nanotechnology. 10(3). 25–34. 4 indexed citations
5.
Balachandran, K., et al.. (2021). Synthesis and Characterization of Ag-Decorated TiO2 Nanoparticles for Photocatalytic Application. Journal of Environmental Nanotechnology. 10(4). 13–18. 2 indexed citations
7.
Balachandran, K., et al.. (2020). Photocatalytic decomposition of A549-lung cancer cancer cells by TiO2 nanoparticles. Materials Today Proceedings. 37. 1071–1074. 9 indexed citations
8.
Lifford, Kate, Adrian Edwards, Maria Burton, et al.. (2019). Efficient development and usability testing of decision support interventions for older women with breast cancer. Patient Preference and Adherence. Volume 13. 131–143. 5 indexed citations
9.
Balachandran, K., Abdulazeez Salawu, Ehsan Ghorani, et al.. (2019). When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patients. Gynecologic Oncology. 155(1). 8–12. 33 indexed citations
10.
Balachandran, K., et al.. (2016). Botanical Hydrocarbon Sources based MWCNTs Synthesized by Spray Pyrolysis Method for DSSC Applications. Silicon. 10(2). 211–217. 17 indexed citations
11.
Balachandran, K. & Justin Stebbing. (2016). Turmeric: a spice for life?. The Lancet Oncology. 17(12). 1639–1639. 4 indexed citations
12.
Balachandran, K., Alicia Okines, R. Gunapala, Daniel L. Morganstein, & Sanjay Popat. (2015). Resolution of severe hyponatraemia is associated with improved survival in patients with cancer. BMC Cancer. 15(1). 163–163. 29 indexed citations
13.
Robey, Rebecca C., et al.. (2014). The Use of Monoclonal Antibodies to Treat Castleman‘s Disease. Immunotherapy. 6(2). 211–219. 3 indexed citations
14.
Balachandran, K., R. Venckatesh, Rajeshwari Sivaraj, & Rajiv Periakaruppan. (2014). TiO2 nanoparticles versus TiO2–SiO2 nanocomposites: A comparative study of photo catalysis on acid red 88. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 128. 468–474. 44 indexed citations
15.
Balachandran, K., R. Venckatesh, & Rajeshwari Sivaraj. (2010). SYNTHESIS OF NANO TIO2-SIO2 COMPOSITE USING SOL–GEL METHOD: EFFECT ON SIZE, SURFACE MORPHOLOGY AND THERMAL STABILITY. 2. 3695–3695. 41 indexed citations
16.
Balachandran, K., et al.. (1975). ChemInform Abstract: OXIDATION WITH METAL OXIDES PART 8, OXIDATION OF BIS‐PHENYLHYDRAZONES OF 1,2‐DIKETONES WITH NICKEL PEROXIDE. Chemischer Informationsdienst. 6(28). 1 indexed citations
17.
Balachandran, K., et al.. (1975). Oxidation with metal oxides—VIII. Tetrahedron. 31(9). 1171–1177. 20 indexed citations
18.
George, M. V. & K. Balachandran. (1975). Nickel-peroxide oxidation of organic compounds. Chemical Reviews. 75(4). 491–519. 91 indexed citations
19.
Balachandran, K. & M. V. George. (1975). Oxidation by metal oxides—IX. Tetrahedron. 31(11-12). 1491–1499.
20.
Balachandran, K. & Samir K. Banerji. (1970). Iron(III) Chelates of substituted 8‐hydroxy quinoline‐7‐sulfonic acids some physico chemical properties and analytical applications. Journal für praktische Chemie. 312(2). 266–271.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026